Comerica Bank lifted its position in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 6.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 78,299 shares of the medical instruments supplier’s stock after purchasing an additional 4,792 shares during the quarter. Comerica Bank’s holdings in Becton, Dickinson and Company were worth $19,375,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of the company. Norges Bank acquired a new position in shares of Becton, Dickinson and Company during the fourth quarter valued at about $761,798,000. Nordea Investment Management AB boosted its stake in Becton, Dickinson and Company by 277.3% during the 1st quarter. Nordea Investment Management AB now owns 1,936,654 shares of the medical instruments supplier’s stock valued at $478,295,000 after purchasing an additional 1,423,353 shares during the last quarter. M&G Plc bought a new stake in Becton, Dickinson and Company during the 1st quarter worth approximately $173,692,000. Cooke & Bieler LP raised its stake in shares of Becton, Dickinson and Company by 117.1% in the fourth quarter. Cooke & Bieler LP now owns 710,932 shares of the medical instruments supplier’s stock worth $173,347,000 after purchasing an additional 383,485 shares during the last quarter. Finally, Magnetar Financial LLC bought a new position in shares of Becton, Dickinson and Company in the first quarter valued at approximately $75,493,000. 86.97% of the stock is currently owned by institutional investors.
Becton, Dickinson and Company Stock Performance
Shares of NYSE:BDX traded up $3.64 during mid-day trading on Friday, reaching $239.65. The company had a trading volume of 456,310 shares, compared to its average volume of 1,451,935. Becton, Dickinson and Company has a one year low of $218.75 and a one year high of $284.48. The company has a current ratio of 1.41, a quick ratio of 0.97 and a debt-to-equity ratio of 0.62. The company’s 50-day moving average price is $232.64 and its 200-day moving average price is $236.24. The firm has a market cap of $69.26 billion, a price-to-earnings ratio of 51.95, a PEG ratio of 2.11 and a beta of 0.42.
Becton, Dickinson and Company Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 9th will be issued a dividend of $0.95 per share. This represents a $3.80 annualized dividend and a yield of 1.59%. The ex-dividend date of this dividend is Monday, September 9th. Becton, Dickinson and Company’s dividend payout ratio (DPR) is presently 83.70%.
Insiders Place Their Bets
In other news, EVP Roland Goette sold 3,300 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $236.70, for a total value of $781,110.00. Following the sale, the executive vice president now owns 14,608 shares of the company’s stock, valued at $3,457,713.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, EVP Roland Goette sold 3,300 shares of the firm’s stock in a transaction on Monday, May 13th. The stock was sold at an average price of $236.70, for a total value of $781,110.00. Following the completion of the transaction, the executive vice president now directly owns 14,608 shares of the company’s stock, valued at $3,457,713.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Thomas J. Spoerel sold 300 shares of the business’s stock in a transaction on Monday, June 10th. The shares were sold at an average price of $239.31, for a total value of $71,793.00. Following the sale, the senior vice president now owns 1,976 shares in the company, valued at $472,876.56. The disclosure for this sale can be found here. Insiders sold 6,900 shares of company stock worth $1,634,112 over the last quarter. 0.31% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
BDX has been the subject of a number of analyst reports. Citigroup lowered their price target on Becton, Dickinson and Company from $260.00 to $255.00 and set a “neutral” rating for the company in a research report on Wednesday, July 10th. Barclays increased their target price on shares of Becton, Dickinson and Company from $305.00 to $312.00 and gave the company an “overweight” rating in a report on Monday, May 6th. Evercore ISI cut their price target on shares of Becton, Dickinson and Company from $290.00 to $285.00 and set an “outperform” rating on the stock in a report on Tuesday, July 2nd. Stifel Nicolaus increased their price objective on shares of Becton, Dickinson and Company from $270.00 to $280.00 and gave the company a “buy” rating in a research note on Friday, July 26th. Finally, StockNews.com downgraded Becton, Dickinson and Company from a “buy” rating to a “hold” rating in a research note on Wednesday. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $280.13.
View Our Latest Stock Analysis on BDX
Becton, Dickinson and Company Company Profile
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.
Featured Stories
- Five stocks we like better than Becton, Dickinson and Company
- What Do S&P 500 Stocks Tell Investors About the Market?
- Amazon Stock is Primed to Rebound Strongly After AI Bubble Bursts
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Shell Stock: Oil & Gas Giant Committed to Buybacks and Dividends
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Chevron Stock Dips as Earnings Miss Highlights Merger Uncertainty
Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.